Literature DB >> 23615930

[Tocilizumab for treatment of large vessel vasculitis and polymyalgia rheumatica].

J C Henes1, T Xenitidis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23615930     DOI: 10.1007/s00393-013-1177-y

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


× No keyword cloud information.
  6 in total

1.  Clinical relevance of persistently elevated circulating cytokines (tumor necrosis factor alpha and interleukin-6) in the long-term followup of patients with giant cell arteritis.

Authors:  Ana García-Martínez; José Hernández-Rodríguez; Georgina Espígol-Frigolé; Sergio Prieto-González; Montserrat Butjosa; Marta Segarra; Ester Lozano; Maria C Cid
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-06       Impact factor: 4.794

Review 2.  Giant cell arteritis and polymyalgia rheumatica: role of cytokines in the pathogenesis and implications for treatment.

Authors:  Victor Manuel Martinez-Taboada; Lorena Alvarez; Maria RuizSoto; Maria Jose Marin-Vidalled; Marcos Lopez-Hoyos
Journal:  Cytokine       Date:  2008-11-04       Impact factor: 3.861

3.  Interleukin-6 and RANTES in Takayasu arteritis: a guide for therapeutic decisions?

Authors:  M Noris; E Daina; S Gamba; S Bonazzola; G Remuzzi
Journal:  Circulation       Date:  1999-07-06       Impact factor: 29.690

4.  Treatment of giant cell arteritis: interleukin-6 as a biologic marker of disease activity.

Authors:  C M Weyand; J W Fulbright; G G Hunder; J M Evans; J J Goronzy
Journal:  Arthritis Rheum       Date:  2000-05

5.  Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes.

Authors:  Anne Proven; Sherine E Gabriel; Carlos Orces; W Michael O'Fallon; Gene G Hunder
Journal:  Arthritis Rheum       Date:  2003-10-15

Review 6.  New treatment strategies in large-vessel vasculitis.

Authors:  Sebastian Unizony; John H Stone; James R Stone
Journal:  Curr Opin Rheumatol       Date:  2013-01       Impact factor: 5.006

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.